The Valley Desk

NCT02935361 · Interventional trial

Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov